Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 2,262	$ (8,340)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation, amortization and accretion	2,766	3,634
Stock-based compensation expense	324	1,432
Derivative warrant liabilities (gain) loss	(5,896)	6,484
Amortization of debt discount and issuance costs	55	302
Inventory write-down	95	51
Other non-cash adjustments	(529)	(50)
Non-cash adjustments from discontinued operations	254	1,176
Changes in operating assets and liabilities:
Accounts receivable, net	(1,794)	(1,566)
Inventories	961	(1,805)
Prepaid expenses and other current assets	(679)	(830)
Accounts payable	1,329	(3,062)
Accrued liabilities	2,341	(3,554)
Other operating assets and liabilities, net	306	3,805
Changes in operating assets and liabilities from discontinued operations	(80)	1,977
Net cash provided by (used in) operating activities	1,715	(346)
Cash flows from investing activities:
Cash received from sales of fixed assets	668	0
Cash payments for fixed asset purchases	(142)	0
Other investing activities	0	(250)
Net cash provided by (used in) investing activities	526	(250)
Cash flows from financing activities:
Proceeds from issuance of stock and warrants	0	86
Net proceeds received from (payments made on) revolving credit facility	1,617	(537)
Payment made to fixed payment arrangements	(2,537)	(2,204)
Payment of stock issuance costs	0	(160)
Payments made to borrowings	(929)	(45)
Net cash used in financing activities	(1,849)	(2,860)
Net change in cash and cash equivalents	392	(3,456)
Cash and cash equivalents at beginning of period	20,006	22,985
Cash and cash equivalents at end of period	20,398	19,529
Supplemental disclosure of cash flow information:
Cash paid for interest	752	2,170
Cash paid for income taxes	1,419	432
Non-cash investing and financing activities:
Other non-cash investing and financing activities	$ 483	$ 0